Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study

OBJECTIVES: To compare the effectiveness of rituximab versus an alternative tumour necrosis factor (TNF) inhibitor (TNFi) in patients with rheumatoid arthritis (RA) with an inadequate response to one previous TNFi. METHODS: SWITCH-RA was a prospective, global, observational, real-life study. Patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Emery, P, Gottenberg, J E, Rubbert-Roth, A, Sarzi-Puttini, P, Choquette, D, Taboada, V M Martínez, Barile-Fabris, L, Moots, R J, Ostor, A, Andrianakos, A, Gemmen, E, Mpofu, C, Chung, C, Gylvin, L Hinsch, Finckh, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431330/
https://www.ncbi.nlm.nih.gov/pubmed/24442884
http://dx.doi.org/10.1136/annrheumdis-2013-203993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431330/
https://www.ncbi.nlm.nih.gov/pubmed/24442884
http://dx.doi.org/10.1136/annrheumdis-2013-203993

Ejemplares similares